ASSESSMENT OF THE EFFICACY OF A SKIN WHITENING COSMETIC PRODUCT OVER 6 WEEKS BY 40 FEMALE ADULT SUBJECTS

The Himalaya Drug Company0 个研究点目标入组 46 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Female subjects
•-Age: 18 to 55 years; both inclusive
•-A subject having given written consent of her free, informed and specific willingness to participate
•-Subjects having skin phototype III, IV and V
•-Subjects having dark spots, freckles, pigmented
•demarcation lines, and uneven tone
•-Subjects having under-eye dark circles with a
•score >=2
•-Subjects having visible fine lines on face
•-A subject having good physical health as
•determined by the Investigator
•-A cooperative subject informed of the importance
•and the duration of the controls, enabling complete respect of the protocols established by the Clinical Centre
•-Female participants must have a negative
•pregnancy test at screening visit and willing to use acceptable contraceptive measures during the study

•-Female subject who is pregnant or breast-feeding
•(or planning to get pregnant during the study)
•-A known history or present condition of allergic
•response to any cosmetic products
•-Subject having skin diseases (e.g. moderate to
•severe acne vulgaris on face or nodulocystic acne,
•psoriasis, active atopic dermatitis, pigmented
•contact dermatitis or other cutaneous
•manifestations), which can interfere with the test
•-Subjects taking oral contraceptive or any hormonal treatment since less than 1.5 month
•-Any treatment, topical or systemic, taken in the
•weeks preceding the test, which is likely to
•interfere with the evaluation of the efficacy of the product(s) being studied
•-Subjects undergoing anti-inflammatory, corticoids
•or retinoids therapy by oral way
•Subject having used depigmenting products, masks
•exfoliant product on the studied zone in last 4
•-Excessive exposure to sunlight (sun bathing,
•swimming, prolong sun exposure) or UV-rays
•within the previous month and during the study
•-Subject who has been deemed by the investigator
•as potentially unable or unwilling to comply with
•the protocol
•-Subject enrolled in another clinical trial during the study period

发起方